[Corrigendum] Telocinobufagin inhibits the epithelial‑to‑mesenchymal transition of breast cancer cells through the PI3K/Akt/Snail signaling pathway

Gao,Yuxue; Shi,Lihong; Cao,Zhen; Zhu,Xuetao; Li,Feng; Wang,Ruyan; Xu,Jinyuan; Zhong,Jinyi; Zhang,Baogang; Lu,Shijun

doi:10.3892/ol.2021.12503

April-2021 Volume 21 Issue 4

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

April-2021 Volume 21 Issue 4

Full Size Image

Correction Open Access

[Corrigendum] Telocinobufagin inhibits the epithelial‑to‑mesenchymal transition of breast cancer cells through the PI3K/Akt/Snail signaling pathway

Authors:
- Yuxue Gao
- Lihong Shi
- Zhen Cao
- Xuetao Zhu
- Feng Li
- Ruyan Wang
- Jinyuan Xu
- Jinyi Zhong
- Baogang Zhang
- Shijun Lu
View Affiliations / Copyright

Affiliations: Department of Clinical Medicine, School of Clinical Medicine, Weifang Medical University, Weifang, Shandong 261053, P.R. China, Department of Pharmacology, Weifang Medical University, Weifang, Shandong 261053, P.R. China, Department of Pathology, Key Clinical Specialty for Pathology of Shandong Province, Affiliated Hospital of Weifang Medical University, Weifang, Shandong 261053, P.R. China

Copyright: © Gao et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article Number: 242
|
Published online on: January 31, 2021

https://doi.org/10.3892/ol.2021.12503
Expand metrics +

Article

Oncol Lett 15: [Related article:] 7837-7845, 2018; DOI: 10.3892/ol.2018.8349

Subsequently to the publication of the above paper, an interested reader drew to the authors’ attention that, on p. 7483, the data panel shown for the ‘Fibronectin, 10 μM TBG/mice’ experiment in Fig. 4C appeared to be overlapping with the data panel shown for the ‘p-Erk, Control’ experiment in Fig. 4D, although the coloration of the panels differed slightly.

Figure 4.

The anti-metastatic effect of TBG in a mouse 4T1 breast tumor model. (A) The body weight of mice was measured 2 times a week and the wet tumor weight was calculated. *P<0.05 vs. control. The results are presented as the mean ± standard error of the mean. (B) Histopathological images of lung sections. Arrows indicate the tumor cells in nodules. (C) Immunohistochemical staining for EMT markers in tumor sections. (D) Immunohistochemical staining for Akt/ERK signaling pathway elements in tumor sections. TBG, telocinobufagin; EMT, epithelial-to-mesenchymal transition; Akt, protein kinase B; ERK, extracellular signal-related kinase.

The authors have re-examined their data, and realized that they copied and pasted the wrong photo for the ‘pErk, control’ panel in Fig. 4D; however, they retained their original data, and the corrected version of the Fig. 4 is shown on the next page.

The authors regret the error that was made in the preparation of the published figure, and confirm that this error did not affect the conclusions reported in the study. The authors are grateful to the editor of Oncology Letters for allowing them the opportunity to publish a Corrigendum, and all the authors agree to this Corrigendum. Furthermore, they apologize to the readership for any inconvenience caused.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

[Corrigendum] Telocinobufagin inhibits the epithelial‑to‑mesenchymal transition of breast cancer cells through the PI3K/Akt/Snail signaling pathway

This article is mentioned in:

Article

Figure 4.

Related Articles